Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHANGHAI STOCK EXCHANGE  >  Jiangsu Hengrui Medicine Co.    600276   CNE0000014W7

JIANGSU HENGRUI MEDICINE CO. (600276)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
11/12/2018 11/13/2018 11/14/2018 11/15/2018 11/16/2018 Date
65.03(c) 65.4(c) 64.13(c) 64.23(c) 62.31 Last
134 921 157 491 135 609 220 143 293 398 Volume
+0.87% +0.57% -1.94% +0.16% -2.99% Change
More quotes
Financials (CNY)
Sales 2018 17 176 M
EBIT 2018 4 477 M
Net income 2018 3 970 M
Finance 2018 8 208 M
Yield 2018 0,17%
Sales 2019 21 921 M
EBIT 2019 5 798 M
Net income 2019 5 109 M
Finance 2019 11 252 M
Yield 2019 0,21%
P/E ratio 2018 58,52
P/E ratio 2019 45,33
EV / Sales2018 13,3x
EV / Sales2019 10,3x
Capitalization 236 B
More Financials
Company
Jiangsu Hengrui Medicine Co., Ltd. engages in the research, development, manufacture, and sale of drugs.It specializes in antineoplastic agents, surgical anesthesia drugs, features infusion, contrast agents, and cardiovascular drugs.Its products include tablets, oral solution, and suspension of... 
Sector
Pharmaceuticals
Calendar
03/11Earnings Release
More about the company
Surperformance© ratings of Jiangsu Hengrui Medicine C
Trading Rating : Investor Rating :
More Ratings
Latest news on JIANGSU HENGRUI MEDICINE C
10/23JIANGSU HENGRUI MEDICINE : LSK BioPharma and Jiangsu Hengrui Medicine Announce G..
AQ
05/30JIANGSU HENGRUI MEDICINE CO LTD : Ex-dividend day for final dividend
FA
05/30JIANGSU HENGRUI MEDICINE CO LTD : BONUS ISSUE: 3 new shares for 10 existing shar..
FA
04/11JIANGSU HENGRUI MEDICINE : Procurement Project for Automatic Labeler Machine for..
AQ
03/28JIANGSU HENGRUI MEDICINE : Procurement Project for Automatic Labeler Machine for..
AQ
03/27JIANGSU HENGRUI MEDICINE CO LTD : annual earnings release
01/09TG THERAPEUTICS : and Jiangsu Hengrui Medicine Announce Global License Agreement..
AQ
01/05JIANGSU HENGRUI MEDICINE : and Arcutis Announce a Development and Commercializat..
BU
2017JIANGSU HENGRUI MEDICINE CO., LTD : Ex-dividend day for final dividend
FA
2017JIANGSU HENGRUI MEDICINE CO., LTD : 20% Stock Dividend
FA
More news
Sector news : Pharmaceuticals - NEC
08:31aASTRAZENECA : Imfinzi Cancer-Drug Trial Misses the Mark
DJ
08:15aSHIRE : Rule 2.9 Announcement
DJ
02:15aJOHNSON & JOHNSON : New jury fails to reach verdict in J&J South Carolina talc c..
RE
12:46aBAYER : California judge orders next Monsanto weed-killer cancer trial for March
RE
11/15British stocks battered on Brexit deal backlash, exporters gain
RE
More sector news : Pharmaceuticals - NEC
Latest Tweets
10/22 Recap | LSK BioPharma and Jiangsu Hengrui Medicine Announce Global Clinical.. 
10/22LSK BioPharma and Jiangsu Hengrui Medicine Announce Global Clinical Collabora.. 
08/03Genome Editing Biotech EdiGene Names Dong Wei, Ph.D., MBA as its Chief Execut.. 
01/08$TGTX: TG Therapeutics and Jiangsu Hengrui Medicine announce global license a.. 
01/05Jiangsu Hengrui Medicine and Arcutis Announce a Development and Commercializa.. 
More tweets
Qtime:45
Chart JIANGSU HENGRUI MEDICINE CO.
Duration : Period :
Jiangsu Hengrui Medicine Co. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JIANGSU HENGRUI MEDICINE C
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 74,2  CNY
Spread / Average Target 15%
EPS Revisions
Managers
NameTitle
Yun Shu Zhou President & Director
Wei Dong Chairman-Supervisory Board
Piao Yang Sun Chairman
Song Zhou Chief Financial Officer
Xin Hua Jiang Vice Chairman
Sector and Competitors
1st jan.Capitalization (M$)
JIANGSU HENGRUI MEDICINE CO.21.05%34 081
JOHNSON & JOHNSON3.24%387 546
PFIZER18.47%250 618
NOVARTIS6.19%221 937
ROCHE HOLDING LTD.0.39%212 046
MERCK AND COMPANY33.00%194 612